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Abstract: In an attempt to isolate new spermatogenesis-associated genes, pd1 was initially identified and cloned as a 
novel human cDNA sequence from testis cDNA library. The novel gene was submitted to GenBank under accession n° 
U28164 in 1996. PD1 expression was demonstrated at the Sertoli cell level with a production which appeared to be under 
the influence of neighbouring spermatogenic cells. The rat orthologue of human pd1 was further cloned and, according to 
the Gene Nomenclature Committee, was renamed spata2 (spermatogenesis-associated protein 2) gene on the basis of its 
FSH-dependent up-regulation and developmental expression. The analysis of the human and rat cDNA sequences dis-
closed an open reading frame for a protein of 520 and 511 amino acids respectively, with an overall identity of 85%. Sub-
sequently, a zebrafish orthologue of the human spata2 gene was identified. The consensus open reading frame (1650 bp) 
encodes a polypeptide of 550 amino acids, which shares 37% identity with the human spata2. By means of whole-mount 
in situ hybridisation it has been shown that spata2 transcripts are maternally derived and become strongly localised in the 
central nervous system at early developmental stages. At the same time, RT-PCR analysis demonstrated that several adult 
zebrafish tissues expressed high level of spata2 mRNA providing evidence that this gene may have a broader function 
than previously described. More recently, novel findings have highlighted a potential role of spata2 during pancreatic de-
velopment and -cell proliferation. In this review we will discuss spata2 gene expression and regulation as well as focus 
on novel evidence, which suggests a role for this protein in pancreatic -cell function. 
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THE BEGINNING OF THE STORY: PD1 AND SER-
TOLI CELLS 
  More than ten years ago our laboratory became involved 
in the effort to isolate new spermatogenesis-associate genes. 
During a screening of a human testis cDNA library, we iso-
lated and cloned a 1.4 kb cDNA sequence by means of a 
RACE-PCR strategy. This sequence turned out to be novel 
and thus was named pd1 and submitted to the GenBank un-
der accession n° U28164 in 1996. Afterwards, a 5’ RACE-
PCR was performed in order to identify the real 5’-end of the 
cDNA and in this way the sequence was extended to 2.6 kb. 
The sequence analysis revealed an ORF of 1560 bp encoding 
a 520 amino acid protein with a predicted molecular weight 
of 58.4 kDa [1]. A Northern blot analysis performed on a 
multiple human tissue mRNA blot showed that the pd1 tran-
script is moderately expressed and that the testis is the tissue 
with highest expression whereas other tissues (spleen, pros-
tate and thymus) have lower level of pd1 expression. To 
complete the expression analysis, we raised and purified 
polyclonal antibodies against a recombinant PD1 fragment 
corresponding to 148 C-terminus amino acids. The immuno-
histochemical analysis on human normal testis showed an 
intense staining of the seminiferous tubules with a clear lo-
calisation to the cytoplasm of the Sertoli cells whereas no  
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reactivity was observed in any spermatogenic cells at any 
maturative level. We then performed a Western-blot analysis 
on crude extract of human testicular cells obtained from fine 
needle aspiration and corresponding various testiculopathies. 
This study recognised a band of the expected size (approxi-
mately 60 kDa) and showed a reduction of PD1 expression 
in protein samples retrieved from patients with hyposper-
matogenesis (sperm count lower than 5 x 10
6/ml) and a fur-
ther reduction in the sample from a subject with Sertoli cell-
only syndrome (complete absence of germ cell). Therefore, 
PD1 expression by the Sertoli cells was not constitutive but 
appeared to be under the influence of neighbouring sper-
matogenic cells. These observations were recently confirmed 
by O’Shaughnessy et al. who studied the effect of germ cell 
depletion on the levels of specific mRNA transcript in mouse 
Sertoli cells and Leydig cells. In this animal model the 
authors demonstrated that out of 26 Sertoli cell markers 
tested,  pd1 (currently named spata2) was one of the two 
genes whose expression decreased as germ cell depletion 
progressed [2]. It has been observed that a similar behaviour 
was characteristic of inhibin B which is a protein secreted by 
Sertoli cells, involved in the feedback regulation of FSH 
secretion and whose expression reflects interactions between 
these cells and neighbouring germ cells [3, 4]. Although 
there was not any homology between pd1 and inhibin B, the 
similar expression pattern with respect to germ cells 
prompted us to hypothesise that PD1 might have a role in the 
regulation of human spermatogenesis [1]. 
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THE RAT ORTHOLOGUE OF HUMAN PD1: SPATA2 
(SPERMATOGENESIS-ASSOCIATED PROTEIN 2) 
  With the aim of further elucidating the role of pd1 on the 
control of spermatogenesis, we decided to isolate the rat 
orthologue of this gene. Using a set of primers designed on 
the basis of human pd1 gene, the entire coding sequence was 
cloned from a rat testis cDNA pool and subsequently com-
pleted with 5’ and 3’ UTR regions [5]. Sequence analysis 
revealed an open reading frame encoding a protein of 511 
amino acids with an overall identity of 85% between human 
and rat proteins. Based on the fact that the basic mechanisms 
underlying the process of sexual development are conserved 
across species and since FSH is the most important molecule 
regulating Sertoli cells function, time-course experiments 
were performed on rat Sertoli cells to study pd1 mRNA ex-
pression following FSH stimulation. This treatment induced, 
in a time-dependent manner, a remarkable increase in pd1 
mRNA level demonstrating that the expression of this pro-
tein is FSH-responsive. In the same report the expression of 
pd1 mRNA in rat testis during testicular development has 
been analysed and clear evidences that pd1 transcripts ap-
peared during the infantile-juvenile period and increased 
steadily with advancement of age were provided. On the 
whole, these results confirmed the hypothesis that PD1 
might play a role in regulating spermatogenesis and, thus, 
according to the Gene Nomenclature Committee, the name 
SPATA2 (Spermatogenesis-associated protein 2) has been 
proposed for this protein. 
THE GENOMIC ORGANIZATION AND EXPRES-
SION PATTERN OF SPATA2 GENE 
  To comprehend the transcriptional control and the ge-
nomic organization of spata2 gene, we decided to character-
ise its promoter region and the functional subregion that con-
trol its expression. Once the exact position of the transcrip-
tion start point was located, the genomic organisation of 
spata2 gene was determined by means of BLASTN align-
ment with genomic sequence deposited in GenBank. In this 
way, we showed that the genomic organisation of spata2 
gene is composed of three exons and two introns spanning a 
region of about 12.1 kb and confirmed the chromosome lo-
calisation at 20q13.13 [6]. 
  A promoter region analysis was also performed which 
revealed the presence of potential binding sites for various 
transcription factors as well as the absence of a canonical 
TATA box. In addition, using a luciferase gene-reporter as-
say it has been demonstrated that the basal promoter activity 
is driven by Sp1 elements near the transcriptional start site 
whereas the strongest promoter activity is determined by the 
-403/+159 region containing a CREB site.  
  It is noteworthy that sequence similarity searches for 
spata2 do not reveal a significant homology to any other 
gene or protein. At the same time, bioinformatic analyses 
reveal a small pattern PW [KR] KE [YF][RK], which ap-
pears to be of particular interest due to its strong conserva-
tion between SPATA2 and the D. melanogaster TAMO pro-
tein. TAMO has been demonstrated to be a protein involved 
in nuclear import machinery during oogenesis in D. mela-
nogaster [7].  
  Subsequently, with the goal of getting new insights into 
SPATA2 function, we decided to identify a potential 
orthologue in zebrafish (Danio rerio). Thanks to its transpar-
ency, at early developmental stages together with its easy 
manipulation and high reproductive capability, this animal 
has become extensively used as a genetic tool to uncover 
specific functions of unknown proteins as well as to study 
human disease [8, 9]. Starting from a zebrafish cDNA li-
brary, we cloned and characterised a 2905 bp cDNA se-
quence which represents the zebrafish orthologue of the hu-
man spata2 gene and whose consensus open reading frame 
(1650 bp) encodes a polypeptide of 550 amino acids sharing 
a 37% identity with the human protein [10]. Whole-mount in 
situ hybridization detected spata2 transcript at two-cell stage 
(thus demonstrating a maternal origin of the transcript), 
whereas at early developmental stages a strong signal was 
ubiquitously visible and became localised in the central 
nervous system by 48 h post fertilisation. To address the 
question as to whether zebrafish spata2 maintains its ubiqui-
tous spatial expression in adult stages, a multi tissue RT-
PCR analysis was performed and it has been demonstrated 
that almost all analysed tissues of adult fish do display a high 
content of spata2 transcripts. A great amount of data, avail-
able on public domain databases (GEO Profile, Gensat) con-
firm this observation highlighting once more that spata2 has 
a wide distribution in several normal and pathological tissues 
and that, among them, testis and brain display the highest 
expression levels. 
  In conclusion, these different analyses performed in ze-
brafish, rodents and human tissues, provided evidence that 
spata2  may have a broader function than previously de-
scribed. 
THE LAST PART OF THE STORY: SPATA2, MIR-7 
AND PANCREATIC ISLETS  
  MicroRNAs (miRNAs) are a novel class of short non-
coding RNAs that regulate gene expression at post-
transcriptional level. They generally bind to the 3’-UTR of 
their target mRNAs, thus inhibiting mRNAs translation [11, 
12]. miRNAs expression is often tissue- or developmental-
specific and plays an important role in the regulation of gene 
expression at specific stages in various biological processes 
such as in the case of the differentiation of endocrine pan-
creas [13, 14]. Human pancreas develop from the ventral and 
dorsal buds of foregut endoderm and its efficient develop-
ment needs spatio-temporal changes in gene expression too. 
Recent data demonstrate the expression of specific miRNAs 
in pancreas and suggest a direct role for miRNAs in mam-
malian insulin secretion [15], as well as during the develop-
ment of pancreatic islets in zebrafish [16]. Bravo-Egana et 
al. performed a differential expression analysis of miRNAs 
in human adult acinar and islets pancreatic tissue and identi-
fied miR-7 to be the most highly and selectively expressed 
miRNA in islets, with an islet/acinar ratio of expression 
greater than 200 [17]. Other studies confirmed the major 
expression of miR-7 during human pancreatic islet develop-
ment and differentiation and revealed the correlation be-
tween its expression and the observed increase in pro-insulin 
gene transcripts [18, 19]. The RNA target predictive algo-
rithms TargetScan, Miranda and PicTar identified spata2 
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miR-7 silencing experiments, performed with anti-miR-7 
morpholinos, demonstrate an increase in the expression of 
spata2 mRNA (in ex vivo cultured islets or in the pancreatic 
-cell line MIN6) thus confirming that spata2 is down-
regulated by miR-7. Since spata2 and miR-7 transcript ex-
pression seems to be inversely correlated, it has been pro-
posed that spata2/miR-7 could be involved in islet biogenesis 
[20]. 
  In any case, a possible link between SPATA2 and pan-
creatic islets was first suggested some years ago by Luca   
et al., who demonstrated that in vitro co-incubation of rat 
pre-pubertal Sertoli cells, or their secreted products, with 
homologous islets resulted in statistically significant increase 
of the islet -cell mitotic index. Using polyclonal antibodies 
against-PD1/SPATA2 provided by our laboratory, they 
showed an evident decline of the Sertoli cells-related pro-
mitogenic effects on the -cells and hence these authors hy-
pothesised that PD1/SPATA2 might be one of the soluble 
factors involved in the induction of -cell mitotic activity 
[21]. Interestingly, preliminary immuno-chemical results 
from our laboratory seem to confirm an endogenous produc-
tion of spata2 by human pancreatic -cells since: 1) in hu-
man normal pancreas sections, an evident positive stain for 
this protein co-localised with that of insulin, which is a 
marker of these endocrine cells; 2) in MIN6 -cell line [22], 
an RT-PCR analysis reveals the presence of spata2 tran-
scripts and an ELISA assay detects the presence of the rela-
tive protein in their conditioned media respectively. 
  On the whole, these pieces of evidence suggest that 
SPATA2 might be produced and secreted by -cells and 
could act as a autocrine/paracrine molecule able to induce a 
pancreatic islets mitogenesis. 
  Whether or not this hypothesis will be confirmed, spata2 
may represent a useful tool in addressing the growing re-
quest of new therapeutic strategies based on -cells renewal 
and aimed at overcoming the well-known phenomenon of -
cells destruction typical of Diabetes mellitus. In this regard, 
many studies are actually targeted at understanding and iden-
tifying those factors that regulate -cells proliferation and 
function [23].  
  The demonstration that spata2 turned out to be a “growth 
factor” for -cells is awaiting the results of further investiga-
tions which are currently in progress in our laboratory. 
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